印度医学研究理事会肝细胞癌共识文件
该共识文件旨在协助肿瘤科医生在印度实践背景下对肝细胞癌患者做出临床决策,基于专家共识。多数患者采用巴塞罗那临床肝癌分期系统进行分期,该系统包括患者体能状态、Child-Pugh分级、结节数量和大小、门静脉侵犯及转移。患者应接受多学科诊疗。
要点
- 巴塞罗那临床肝癌分期系统包括体能状态、Child-Pugh分级、结节数量和大小、门静脉侵犯及转移。
- 手术切除和移植是根治性治疗的主要手段。
- 对于不适合手术切除的小肿瘤(<3 cm)患者(Child B和C级),采用消融技术。
诊断标准与关键数值
- 巴塞罗那临床肝癌分期系统包括患者体能状态、Child-Pugh状态、结节数量和大小、门静脉侵犯及转移。
- 消融技术用于小肿瘤(<3 cm)且不适合手术切除的患者(Child B和C级)。
临床应用与阅片要点
- 患者应接受多学科诊疗。
- 手术切除和移植是根治性治疗的主要手段。
- 不适合手术切除的小肿瘤(<3 cm)患者(Child B和C级)采用消融技术。
- 晚期肝细胞癌患者应个体化评估,以确定应提供靶向治疗、介入放射学操作还是最佳支持治疗。
- 根治性切除或晚期疾病治疗完成后,患者应接受定期监测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This document aims to assist oncologists in making clinical decisions encountered while managing their patients with hepatocellular carcinoma (HCC), specific to Indian practice, based on consensus among experts. Most patients are staged by Barcelona Clinic Liver Cancer (BCLC) staging system which comprises patient performance status, Child-Pugh status, number and size of nodules, portal vein invasion and metastasis. Patients should receive multidisciplinary care. Surgical resection and transplant forms the mainstay of curative treatment. Ablative techniques are used for small tumours (<3 cm) in patients who are not candidates for surgical resection (Child B and C). Patients with advanced (HCC should be assessed on an individual basis to determine whether targeted therapy, interventional radiology procedures or best supportive care should be provided. In advanced HCC, immunotherapy, newer targeted therapies and modern radiation therapy have shown promising results. Patients should be offered regular surveillance after completion of curative resection or treatment of advanced disease.
引用
- Sirohi B, Shrikhande SV, Gaikwad V, et al. Indian Council of Medical Research consensus document on hepatocellular carcinoma. Indian J Med Res. 2020. PMID: 33707388. doi:10.4103/ijmr.IJMR_404_20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。